V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250006669 | 250004722 | null | null | Palliative (P) | 2017-08-03 | 2017-08-23 | ANAGRELIDE | N | N | 250029920 | RUXOLITINIB |
| 250006670 | 250004723 | null | 0 | Palliative (P) | 2016-01-27 | 2016-01-27 | RUXOLITINIB | 2 | N | 250029926 | RUXOLITINIB |
| 250006672 | 250004725 | 1.73 | null | Palliative (P) | 2016-01-29 | 2016-01-29 | FLAG + Idarubicin | null | N | 250029929 | RUXOLITINIB |
| 250006673 | 250004726 | 1.78 | 0 | Disease modification (D) | 2018-04-30 | 2018-04-30 | ANAGRELIDE | 02 | N | 250029932 | RITUXIMAB |
| 250006674 | 250004727 | 1.7 | 70 | Curative (C) | 2017-06-10 | 2017-06-11 | Azacitidine | N | N | 250029934 | RUXOLITINIB |
| 250006675 | 250004728 | 1.74 | 64.9 | Palliative (P) | 2013-07-25 | 2013-07-25 | Cytarabine High Dose | N | N | 250029936 | INTERFERON |
| 250006676 | 250004728 | null | 49.5 | Palliative (P) | 2016-06-08 | 2016-07-24 | RUXOLITINIB | N | N | 250029936 | ENZALUTAMIDE |
| 250006678 | 250004730 | 1.67 | 0 | Palliative (P) | 2018-03-03 | 2018-03-03 | RUXOLITINIB | N | N | 250029945 | CHOP R |
| 250006679 | 250004731 | null | 84.7 | Palliative (P) | 2016-10-14 | 2016-10-23 | RUXOLITINIB | 02 | N | 250029946 | RUXOLITINIB |
| 250006680 | 250004731 | 1.57 | 46.8 | Palliative (P) | 2017-06-23 | 2017-07-14 | RUXOLITINIB | N | null | 250029946 | RUXOLITINIB |
| 250006681 | 250004731 | 0 | 0 | Palliative (P) | 2016-12-11 | 2016-12-22 | Chlorambucil | Y | N | 250029946 | RUXOLITINIB |
| 250006682 | 250004731 | null | 88.2 | Palliative (P) | 2017-02-21 | 2017-02-21 | INTERFERON | 2 | N | 250029946 | BUSULPHAN |
| 250006683 | 250004732 | null | null | Disease modification (D) | null | 2017-10-12 | Azacitidine | null | N | 250029952 | PEG INTERFERON |
| 250006684 | 250004733 | 1.81 | 65.5 | Palliative (P) | 2015-11-11 | 2015-11-11 | CHOP R - 21 days | N | null | 250029954 | PEG INTERFERON |
| 250006685 | 250004734 | null | null | Palliative (P) | 2015-06-16 | 2015-07-08 | ANAGRELIDE | N | N | 250029956 | BENDAMUSTINE + RITUXIMAB |
| 250006686 | 250004735 | 1.73 | 56 | Palliative (P) | 2015-12-05 | 2016-01-06 | RUXOLITINIB | N | N | 250029962 | RUXOLITINIB |
| 250006687 | 250004736 | 1.84 | 82.6 | Disease modification (D) | 2015-04-12 | 2015-04-13 | RUXOLITINIB | 2 | N | 250029965 | RUXOLITINIB |
| 250006688 | 250004737 | 1.75 | 0 | Disease modification (D) | 2014-04-17 | 2014-04-17 | BUSULFAN | 02 | N | 250029966 | RUXOLITINIB |
| 250006689 | 250009583 | null | 89.85 | Palliative (P) | 2015-10-02 | 2015-10-11 | Rituximab | null | N | 250029972 | RUXOLITINIB |
| 250006690 | 250009583 | 1.74 | 0 | Palliative (P) | 2015-02-14 | 2015-02-15 | BENDAMUSTINE + RITUXIMAB | N | N | 250029972 | NILOTINIB |
| 250006691 | 250009583 | 1.75 | 74.5 | Palliative (P) | 2013-12-27 | 2014-01-05 | INTERFERON | N | N | 250029972 | RUXOLITINIB |
| 250006692 | 250009583 | null | null | Palliative (P) | 2016-08-07 | 2016-08-07 | RUXOLITINIB | N | N | 250029972 | CHLORAMBUCIL + OBINUTUZUMAB |
| 250006693 | 250009583 | null | null | null | 2018-08-23 | 2018-08-23 | CVP R | N | N | 250029972 | LENALIDOMIDE |
| 250006694 | 250012892 | 1.73 | 66.3 | Disease modification (D) | 2015-04-10 | 2015-04-12 | Trial Unspecified | 2 | N | 250029986 | CAPECITABINE + OXALIPLATIN |
| 250006695 | 250004738 | 1.57 | 71.6 | Adjuvant (A) | 2017-08-30 | 2017-08-30 | RUXOLITINIB | N | N | 250029987 | RITUXIMAB |
| 250006696 | 250004739 | 0 | 70.7 | Palliative (P) | 2015-09-04 | 2015-09-04 | Trial Unspecified | 2 | N | 250029990 | RUXOLITINIB |
| 250006697 | 250004740 | 1.49 | 47.3 | Disease modification (D) | 2015-02-24 | 2015-02-24 | RUXOLITINIB | N | N | 250029991 | RITUXIMAB |
| 250006698 | 250009584 | 1.61 | 81.7 | Palliative (P) | 2015-02-28 | 2015-03-09 | RUXOLITINIB | 2 | null | 250029994 | TRIAL |
| 250006699 | 250004741 | 1.46 | null | Palliative (P) | null | 2017-07-11 | Azacitidine | N | N | 250030001 | BENDAMUSTINE + RITUXIMAB |
| 250006700 | 250004742 | null | 82.4 | Curative (C) | 2014-12-28 | 2014-12-28 | Bortezomib +/- Dexamethasone | 1 | null | 250030005 | RUXOLITINIB |
| 250006701 | 250004743 | 1.75 | 95.7 | null | 2017-05-26 | 2017-05-27 | PEG INTERFERON | 02 | null | 250030006 | RUXOLITINIB |
| 250006702 | 250004744 | 1.55 | null | Palliative (P) | null | 2016-01-14 | IMATINIB | null | N | 250030010 | RUXOLITINIB |
| 250006703 | 250004745 | 0 | 84.6 | Disease modification (D) | 2016-06-17 | 2016-07-07 | PEG INTERFERON | 02 | N | 250030015 | RUXOLITINIB |
| 250006704 | 250004746 | 1.7 | 89 | Disease modification (D) | 2014-01-17 | 2014-01-17 | Azacitidine | N | N | 250030018 | RUXOLITINIB |
| 250006706 | 250004748 | -1 | 83 | Adjuvant (A) | 2017-10-06 | 2017-10-07 | PEG INTERFERON | null | N | 250030021 | RUXOLITINIB |
| 250006707 | 250009585 | null | 66.2 | Palliative (P) | 2014-03-07 | 2014-03-07 | Busulfan Oral | null | N | 250030023 | INTERFERON |
| 250006708 | 250009585 | 1.4 | null | Disease modification (D) | 2014-09-05 | 2014-09-05 | Azacitidine | N | null | 250030023 | PAZOPANIB |
| 250006709 | 250004749 | 1.67 | 74 | Palliative (P) | null | 2018-04-13 | BUSULFAN | N | N | 250030030 | PEG INTERFERON |
| 250006710 | 250004750 | 0 | 65.4 | Curative (C) | 2013-07-12 | 2013-08-28 | Chlorambucil | Y | N | 250030031 | TRIAL |
| 250006711 | 250004751 | 1.55 | null | Adjuvant (A) | 2013-04-10 | 2013-04-12 | Carboplatin + Paclitaxel (3 weekly) | N | N | 250030033 | VINORELBINE |
| 250006712 | 250004751 | 1.78 | 86.7 | Disease modification (D) | 2014-02-02 | 2014-02-02 | RUXOLITINIB | 2 | N | 250030033 | IMATINIB |
| 250006714 | 250009587 | 1.61 | 68.1 | Palliative (P) | 2014-04-08 | 2014-04-14 | BUSULFAN | 02 | null | 250030040 | RUXOLITINIB |
| 250006715 | 250004753 | 1.63 | 75.2 | Curative (C) | 2015-08-18 | 2015-08-20 | RUXOLITINIB | N | N | 250030042 | AZACITIDINE |
| 250006716 | 250004753 | 1.6 | 99.4 | Disease modification (D) | 2013-07-14 | 2013-07-26 | IMATINIB | N | N | 250030042 | RITUXIMAB |
| 250006717 | 250011559 | 0 | 88.9 | Palliative (P) | 2014-08-13 | 2014-09-28 | IBRUTINIB | N | N | 250030050 | ANAGRELIDE |
| 250006718 | 250011559 | 0 | 57 | Palliative (P) | 2018-01-03 | 2018-01-03 | RUXOLITINIB | N | N | 250030050 | RUXOLITINIB |
| 250006719 | 250004754 | null | 96.6 | Adjuvant (A) | 2017-08-29 | 2017-09-02 | RUXOLITINIB | 2 | N | 250030068 | RUXOLITINIB |
| 250006720 | 250004755 | 1.7 | null | Palliative (P) | 2014-11-01 | 2014-11-03 | PEG INTERFERON | 02 | N | 250030070 | INTERFERON |
| 250006721 | 250004756 | null | 60.8 | Disease modification (D) | 2014-09-29 | 2014-09-29 | BUSULFAN | N | N | 250030071 | CYTARABINE HIGH DOSE |
| 250006722 | 250004757 | 1.6 | 78 | Palliative (P) | 2017-12-28 | 2018-01-14 | PEG INTERFERON | 02 | N | 250030078 | RUXOLITINIB |